Reason for request
Inclusion on the list of medicines approved for hospital use.
Clinical Benefit
| Substantial |
The actual benefit of this medicinal product is substantial. |
Clinical Added Value
| moderate |
BERINERT provides a moderate improvement in actual benefit (IAB III) in terms of effectiveness in managing episodes of hereditary angioedema in adults and children. |
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
W0D6fwu06LDF0e4g
